Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer

NCT01196234 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Paclitaxel/Carboplatin/Gefitinib
DRUG: Paclitaxel/Carboplatin

Sponsor

Asan Medical Center

Collaborators

[object Object]